> top > docs > PubMed:16920333 > annotations

PubMed:16920333 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-154 Sentence denotes Anticonvulsant effect of eslicarbazepine acetate (BIA 2-093) on seizures induced by microperfusion of picrotoxin in the hippocampus of freely moving rats.
T2 155-474 Sentence denotes Eslicarbazepine acetate (BIA 2-093, S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide) is a novel antiepileptic drug, now in Phase III clinical trials, designed with the aim of improving efficacy and safety in comparison with the structurally related drugs carbamazepine (CBZ) and oxcarbazepine (OXC).
T3 475-694 Sentence denotes We have studied the effects of oral treatment with eslicarbazepine acetate on a whole-animal model in which partial seizures can be elicited repeatedly on different days without changes in threshold or seizure patterns.
T4 695-845 Sentence denotes In the animals treated with threshold doses of picrotoxin, the average number of seizures was 2.3+/-1.2, and average seizure duration was 39.5+/-8.4s.
T5 846-962 Sentence denotes Pre-treatment with a dose of 30 mg/kg 2h before picrotoxin microperfusion prevented seizures in the 75% of the rats.
T6 963-1161 Sentence denotes Lower doses (3 and 10mg/kg) did not suppress seizures, however, after administration of 10mg/kg, significant reductions in seizures duration (24.3+/-6.8s) and seizure number (1.6+/-0.34) were found.
T7 1162-1318 Sentence denotes No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 120-131 OrganismTaxon denotes hippocampus NCBItxid:72046
T2 149-153 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T5 957-961 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
3353 25-48 ChemicalEntity denotes eslicarbazepine acetate MESH:C416835
3354 50-59 ChemicalEntity denotes BIA 2-093 MESH:C416835
3355 64-72 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3356 102-112 ChemicalEntity denotes picrotoxin MESH:D010852
3357 149-153 OrganismTaxon denotes rats NCBITaxon:10116
3358 155-178 ChemicalEntity denotes Eslicarbazepine acetate MESH:C416835
3359 180-189 ChemicalEntity denotes BIA 2-093 MESH:C416835
3360 191-258 ChemicalEntity denotes S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide MESH:C416835
3361 271-289 ChemicalEntity denotes antiepileptic drug MESH:D000927
3362 430-443 ChemicalEntity denotes carbamazepine MESH:D002220
3363 445-448 ChemicalEntity denotes CBZ MESH:D002220
3364 454-467 ChemicalEntity denotes oxcarbazepine MESH:C036006
3365 469-472 ChemicalEntity denotes OXC MESH:C036006
3366 526-549 ChemicalEntity denotes eslicarbazepine acetate MESH:C416835
3367 591-599 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3368 677-684 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
3369 742-752 ChemicalEntity denotes picrotoxin MESH:D010852
3370 776-784 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3371 812-819 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
3372 894-904 ChemicalEntity denotes picrotoxin MESH:D010852
3373 930-938 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3374 957-961 OrganismTaxon denotes rats NCBITaxon:10116
3375 1008-1016 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3376 1086-1094 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
3377 1122-1129 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
3378 1184-1207 ChemicalEntity denotes eslicarbazepine acetate MESH:C416835

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 41-48 GeneOrGeneProduct denotes acetate
T2 50-55 GeneOrGeneProduct denotes BIA 2
T3 64-72 GeneOrGeneProduct denotes seizures
T4 73-80 GeneOrGeneProduct denotes induced
T5 171-178 GeneOrGeneProduct denotes acetate
T6 180-185 GeneOrGeneProduct denotes BIA 2
T7 265-270 GeneOrGeneProduct denotes novel
T8 304-307 GeneOrGeneProduct denotes III
T9 542-549 GeneOrGeneProduct denotes acetate
T10 591-599 GeneOrGeneProduct denotes seizures
T11 677-684 GeneOrGeneProduct denotes seizure
T12 776-784 GeneOrGeneProduct denotes seizures
T13 789-792 GeneOrGeneProduct denotes 2.3
T14 812-819 GeneOrGeneProduct denotes seizure
T15 878-880 GeneOrGeneProduct denotes mg
T16 930-938 GeneOrGeneProduct denotes seizures
T17 976-981 GeneOrGeneProduct denotes 3 and
T18 1008-1016 GeneOrGeneProduct denotes seizures
T19 1086-1094 GeneOrGeneProduct denotes seizures
T20 1122-1129 GeneOrGeneProduct denotes seizure
T21 1200-1207 GeneOrGeneProduct denotes acetate
T22 1229-1239 GeneOrGeneProduct denotes behavioral
T23 1278-1289 GeneOrGeneProduct denotes wakefulness
T24 1290-1295 GeneOrGeneProduct denotes cycle

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 50-55 GeneOrGeneProduct denotes BIA 2
T2 64-72 GeneOrGeneProduct denotes seizures
T3 180-185 GeneOrGeneProduct denotes BIA 2
T4 265-270 GeneOrGeneProduct denotes novel
T5 591-599 GeneOrGeneProduct denotes seizures
T6 677-684 GeneOrGeneProduct denotes seizure
T7 776-784 GeneOrGeneProduct denotes seizures
T8 812-819 GeneOrGeneProduct denotes seizure
T9 930-938 GeneOrGeneProduct denotes seizures
T10 1008-1016 GeneOrGeneProduct denotes seizures
T11 1086-1094 GeneOrGeneProduct denotes seizures
T12 1122-1129 GeneOrGeneProduct denotes seizure
T13 1290-1295 GeneOrGeneProduct denotes cycle

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 64-72 DiseaseOrPhenotypicFeature denotes seizures D012640
T2 583-599 DiseaseOrPhenotypicFeature denotes partial seizures D012640
T3 677-684 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 776-784 DiseaseOrPhenotypicFeature denotes seizures D012640
T5 812-819 DiseaseOrPhenotypicFeature denotes seizure D012640
T6 930-938 DiseaseOrPhenotypicFeature denotes seizures D012640
T7 1008-1016 DiseaseOrPhenotypicFeature denotes seizures D012640
T8 1086-1094 DiseaseOrPhenotypicFeature denotes seizures D012640
T9 1122-1129 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 600-603 DiseaseOrPhenotypicFeature denotes can 0012833

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 64-72 DiseaseOrPhenotypicFeature denotes seizures D012640
T2 583-599 DiseaseOrPhenotypicFeature denotes partial seizures D012640
T3 677-684 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 776-784 DiseaseOrPhenotypicFeature denotes seizures D012640
T5 812-819 DiseaseOrPhenotypicFeature denotes seizure D012640
T6 930-938 DiseaseOrPhenotypicFeature denotes seizures D012640
T7 1008-1016 DiseaseOrPhenotypicFeature denotes seizures D012640
T8 1086-1094 DiseaseOrPhenotypicFeature denotes seizures D012640
T9 1122-1129 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 64-72 DiseaseOrPhenotypicFeature denotes seizures D012640
T2 583-599 DiseaseOrPhenotypicFeature denotes partial seizures D012640
T3 677-684 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 776-784 DiseaseOrPhenotypicFeature denotes seizures D012640
T5 812-819 DiseaseOrPhenotypicFeature denotes seizure D012640
T6 930-938 DiseaseOrPhenotypicFeature denotes seizures D012640
T7 1008-1016 DiseaseOrPhenotypicFeature denotes seizures D012640
T8 1086-1094 DiseaseOrPhenotypicFeature denotes seizures D012640
T9 1122-1129 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 25-48 ChemicalEntity denotes eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T3 50-59 ChemicalEntity denotes BIA 2-093 C416835
T4 102-112 ChemicalEntity denotes picrotoxin D010852|http://purl.obolibrary.org/obo/CHEBI_134126
T6 155-178 ChemicalEntity denotes Eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T8 180-189 ChemicalEntity denotes BIA 2-093 C416835
T9 200-207 ChemicalEntity denotes acetoxy http://purl.obolibrary.org/obo/CHEBI_48076
T10 222-244 ChemicalEntity denotes 5H-dibenzo/b,f/azepine http://purl.obolibrary.org/obo/CHEBI_47802
T11 247-258 ChemicalEntity denotes carboxamide http://purl.obolibrary.org/obo/CHEBI_37622|http://purl.obolibrary.org/obo/CHEBI_23004
T13 271-289 ChemicalEntity denotes antiepileptic drug ChemicalEntity
T14 430-443 ChemicalEntity denotes carbamazepine D002220|http://purl.obolibrary.org/obo/CHEBI_3387
T16 445-448 ChemicalEntity denotes CBZ D002220
T17 454-467 ChemicalEntity denotes oxcarbazepine D000078330|http://purl.obolibrary.org/obo/CHEBI_7824
T19 469-472 ChemicalEntity denotes OXC D000078330
T20 526-549 ChemicalEntity denotes eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T22 742-752 ChemicalEntity denotes picrotoxin D010852|http://purl.obolibrary.org/obo/CHEBI_134126
T24 894-904 ChemicalEntity denotes picrotoxin D010852|http://purl.obolibrary.org/obo/CHEBI_134126
T26 1184-1207 ChemicalEntity denotes eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T28 1240-1243 ChemicalEntity denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 50-53 OrganismTaxon denotes BIA
T2 149-153 OrganismTaxon denotes rats
T3 180-183 OrganismTaxon denotes BIA
T4 957-961 OrganismTaxon denotes rats

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T28 1240-1243 ChemicalEntity denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T26 1184-1207 ChemicalEntity denotes eslicarbazepine acetate http://purl.obolibrary.org/obo/CHEBI_87016|C416835
T24 894-904 ChemicalEntity denotes picrotoxin http://purl.obolibrary.org/obo/CHEBI_134126|D010852
T22 742-752 ChemicalEntity denotes picrotoxin http://purl.obolibrary.org/obo/CHEBI_134126|D010852
T20 526-549 ChemicalEntity denotes eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T19 469-472 ChemicalEntity denotes OXC D000078330
T17 454-467 ChemicalEntity denotes oxcarbazepine http://purl.obolibrary.org/obo/CHEBI_7824|D000078330
T16 445-448 ChemicalEntity denotes CBZ D002220
T14 430-443 ChemicalEntity denotes carbamazepine D002220|http://purl.obolibrary.org/obo/CHEBI_3387
T13 271-289 ChemicalEntity denotes antiepileptic drug ChemicalEntity
T11 247-258 ChemicalEntity denotes carboxamide http://purl.obolibrary.org/obo/CHEBI_23004|http://purl.obolibrary.org/obo/CHEBI_37622
T10 222-244 ChemicalEntity denotes 5H-dibenzo/b,f/azepine http://purl.obolibrary.org/obo/CHEBI_47802
T9 200-207 ChemicalEntity denotes acetoxy http://purl.obolibrary.org/obo/CHEBI_48076
T8 180-189 ChemicalEntity denotes BIA 2-093 C416835
T6 155-178 ChemicalEntity denotes Eslicarbazepine acetate http://purl.obolibrary.org/obo/CHEBI_87016|C416835
T4 102-112 ChemicalEntity denotes picrotoxin http://purl.obolibrary.org/obo/CHEBI_134126|D010852
T3 50-59 ChemicalEntity denotes BIA 2-093 C416835
T1 25-48 ChemicalEntity denotes eslicarbazepine acetate http://purl.obolibrary.org/obo/CHEBI_87016|C416835
T30246 1122-1129 DiseaseOrPhenotypicFeature denotes seizure D012640
T4732 1086-1094 DiseaseOrPhenotypicFeature denotes seizures D012640
T7 1008-1016 DiseaseOrPhenotypicFeature denotes seizures D012640
T54817 930-938 DiseaseOrPhenotypicFeature denotes seizures D012640
T5 812-819 DiseaseOrPhenotypicFeature denotes seizure D012640
T78533 776-784 DiseaseOrPhenotypicFeature denotes seizures D012640
T74100 677-684 DiseaseOrPhenotypicFeature denotes seizure D012640
T2 583-599 DiseaseOrPhenotypicFeature denotes partial seizures D012640
T27790 64-72 DiseaseOrPhenotypicFeature denotes seizures D012640
T14038 957-961 OrganismTaxon denotes rats
T36705 180-183 OrganismTaxon denotes BIA
T24825 149-153 OrganismTaxon denotes rats
T44035 50-53 OrganismTaxon denotes BIA